Selected research
Industry Growth & Trends
Global Met-Enkephalin Industry Growth and Trends Forecast to 2032
Market perspective
The global Met-Enkephalin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Met-Enkephalin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Met-Enkephalin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Met-Enkephalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Met-Enkephalin include Thermo Scientific, Neuromics, Genscript, Cayman Chemical, Bachem, Abcam, Abbiotec and Aapptec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Met-Enkephalin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Met-Enkephalin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Met-Enkephalin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Met-Enkephalin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Met-Enkephalin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Met-Enkephalin Market by Company
Thermo Scientific
Neuromics
Genscript
Cayman Chemical
Bachem
Abcam
Abbiotec
Aapptec
Met-Enkephalin Segment by Type
Mouse
Rabbit
Human
Rat
Met-Enkephalin Segment by Application
Scientific Research
Medical
Others
Met-Enkephalin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Met-Enkephalin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Met-Enkephalin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Met-Enkephalin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Met-Enkephalin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Met-Enkephalin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mouse
- Rabbit
- Human
- Rat
Applications
- Scientific Research
- Medical
- Others
Companies covered
- Thermo Scientific
- Neuromics
- Genscript
- Cayman Chemical
- Bachem
- Abcam
- Abbiotec
- Aapptec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Met-Enkephalin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Met-Enkephalin Sales Estimates and Forecasts (2021-2032)
- 1.3 Met-Enkephalin Market by Type
- 1.3.1 Mouse
- 1.3.2 Rabbit
- 1.3.3 Human
- 1.3.4 Rat
- 1.4 Global Met-Enkephalin Market Size by Type
- 1.4.1 Global Met-Enkephalin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Met-Enkephalin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Met-Enkephalin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Met-Enkephalin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Met-Enkephalin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Met-Enkephalin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Met-Enkephalin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Met-Enkephalin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Met-Enkephalin Industry Trends
- 2.2 Met-Enkephalin Industry Drivers
- 2.3 Met-Enkephalin Industry Opportunities and Challenges
- 2.4 Met-Enkephalin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Met-Enkephalin Revenue (2021-2026)
- 3.2 Global Top Players by Met-Enkephalin Sales (2021-2026)
- 3.3 Global Top Players by Met-Enkephalin Price (2021-2026)
- 3.4 Global Met-Enkephalin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Met-Enkephalin Major Company Production Sites & Headquarters
- 3.6 Global Met-Enkephalin Company, Product Type & Application
- 3.7 Global Met-Enkephalin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Met-Enkephalin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Met-Enkephalin Players Market Share by Revenue in 2025
- 3.8.3 2025 Met-Enkephalin Tier 1, Tier 2, and Tier 3
4 Met-Enkephalin Regional Status and Outlook
- 4.1 Global Met-Enkephalin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Met-Enkephalin Historic Market Size by Region
- 4.2.1 Global Met-Enkephalin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Met-Enkephalin Sales in Value by Region (2021-2026)
- 4.2.3 Global Met-Enkephalin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Met-Enkephalin Forecasted Market Size by Region
- 4.3.1 Global Met-Enkephalin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Met-Enkephalin Sales in Value by Region (2027-2032)
- 4.3.3 Global Met-Enkephalin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Met-Enkephalin by Application
- 5.1 Met-Enkephalin Market by Application
- 5.1.1 Scientific Research
- 5.1.2 Medical
- 5.1.3 Others
- 5.2 Global Met-Enkephalin Market Size by Application
- 5.2.1 Global Met-Enkephalin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Met-Enkephalin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Met-Enkephalin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Met-Enkephalin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Met-Enkephalin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Met-Enkephalin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Met-Enkephalin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Met-Enkephalin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Thermo Scientific
- 6.1.1 Thermo Scientific Company Information
- 6.1.2 Thermo Scientific Business Overview
- 6.1.3 Thermo Scientific Met-Enkephalin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Thermo Scientific Met-Enkephalin Product Portfolio
- 6.1.5 Thermo Scientific Recent Developments
- 6.2 Neuromics
- 6.2.1 Neuromics Company Information
- 6.2.2 Neuromics Business Overview
- 6.2.3 Neuromics Met-Enkephalin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Neuromics Met-Enkephalin Product Portfolio
- 6.2.5 Neuromics Recent Developments
- 6.3 Genscript
- 6.3.1 Genscript Company Information
- 6.3.2 Genscript Business Overview
- 6.3.3 Genscript Met-Enkephalin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Genscript Met-Enkephalin Product Portfolio
- 6.3.5 Genscript Recent Developments
- 6.4 Cayman Chemical
- 6.4.1 Cayman Chemical Company Information
- 6.4.2 Cayman Chemical Business Overview
- 6.4.3 Cayman Chemical Met-Enkephalin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Cayman Chemical Met-Enkephalin Product Portfolio
- 6.4.5 Cayman Chemical Recent Developments
- 6.5 Bachem
- 6.5.1 Bachem Company Information
- 6.5.2 Bachem Business Overview
- 6.5.3 Bachem Met-Enkephalin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Bachem Met-Enkephalin Product Portfolio
- 6.5.5 Bachem Recent Developments
- 6.6 Abcam
- 6.6.1 Abcam Company Information
- 6.6.2 Abcam Business Overview
- 6.6.3 Abcam Met-Enkephalin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Abcam Met-Enkephalin Product Portfolio
- 6.6.5 Abcam Recent Developments
- 6.7 Abbiotec
- 6.7.1 Abbiotec Company Information
- 6.7.2 Abbiotec Business Overview
- 6.7.3 Abbiotec Met-Enkephalin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Abbiotec Met-Enkephalin Product Portfolio
- 6.7.5 Abbiotec Recent Developments
- 6.8 Aapptec
- 6.8.1 Aapptec Company Information
- 6.8.2 Aapptec Business Overview
- 6.8.3 Aapptec Met-Enkephalin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Aapptec Met-Enkephalin Product Portfolio
- 6.8.5 Aapptec Recent Developments
7 North America by Country
- 7.1 North America Met-Enkephalin Sales by Country
- 7.1.1 North America Met-Enkephalin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Met-Enkephalin Sales by Country (2021-2026)
- 7.1.3 North America Met-Enkephalin Sales Forecast by Country (2027-2032)
- 7.2 North America Met-Enkephalin Market Size by Country
- 7.2.1 North America Met-Enkephalin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Met-Enkephalin Market Size by Country (2021-2026)
- 7.2.3 North America Met-Enkephalin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Met-Enkephalin Sales by Country
- 8.1.1 Europe Met-Enkephalin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Met-Enkephalin Sales by Country (2021-2026)
- 8.1.3 Europe Met-Enkephalin Sales Forecast by Country (2027-2032)
- 8.2 Europe Met-Enkephalin Market Size by Country
- 8.2.1 Europe Met-Enkephalin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Met-Enkephalin Market Size by Country (2021-2026)
- 8.2.3 Europe Met-Enkephalin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Met-Enkephalin Sales by Country
- 9.1.1 Asia-Pacific Met-Enkephalin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Met-Enkephalin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Met-Enkephalin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Met-Enkephalin Market Size by Country
- 9.2.1 Asia-Pacific Met-Enkephalin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Met-Enkephalin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Met-Enkephalin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Met-Enkephalin Sales by Country
- 10.1.1 South America Met-Enkephalin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Met-Enkephalin Sales by Country (2021-2026)
- 10.1.3 South America Met-Enkephalin Sales Forecast by Country (2027-2032)
- 10.2 South America Met-Enkephalin Market Size by Country
- 10.2.1 South America Met-Enkephalin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Met-Enkephalin Market Size by Country (2021-2026)
- 10.2.3 South America Met-Enkephalin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Met-Enkephalin Sales by Country
- 11.1.1 Middle East and Africa Met-Enkephalin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Met-Enkephalin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Met-Enkephalin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Met-Enkephalin Market Size by Country
- 11.2.1 Middle East and Africa Met-Enkephalin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Met-Enkephalin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Met-Enkephalin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Met-Enkephalin Value Chain Analysis
- 12.1.1 Met-Enkephalin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Met-Enkephalin Production Mode & Process
- 12.2 Met-Enkephalin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Met-Enkephalin Distributors
- 12.2.3 Met-Enkephalin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst